With Ozempic (and Wegovy ): Digestive issues such as nausea, vomiting, diarrhea, constipation, or stomach pain are common when starting or increasing the dose
Zhang Q, Delessa CT, Augustin R et al (2021) The glucose-dependent insulinotropic polypeptide (GIP) regulates body weight and food intake via CNS-GIPR signaling
Hyperglucagonemia and its suppression
GLP-1 is usually produced in the small intestine
What this means for DrWell patients is that the availability and formulation of compounded tirzepatide may change over time as regulations evolve
Reconstitution errors (shaking instead of swirling, room-temperature mixing, improper storage) denature peptide structure and shorten effective presence before administration occurs